Telix Pharmaceuticals Limited
TLPPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $710 | $123 | $116 | $22 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $159 | $80 | $31 | $21 |
| Inventory | $38 | $17 | $6 | $3 |
| Other Curr. Assets | $11 | $5 | $57 | $1 |
| Total Curr. Assets | $919 | $225 | $173 | $48 |
| Property Plant & Equip (Net) | $54 | $30 | $19 | $6 |
| Goodwill | $107 | $5 | $6 | $4 |
| Intangibles | $309 | $105 | $59 | $56 |
| Long-Term Investments | $6 | $12 | -$6 | $0 |
| Tax Assets | $47 | $20 | $9 | $0 |
| Other NC Assets | $75 | $1 | $0 | -$4 |
| Total NC Assets | $598 | $173 | $87 | $62 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,516 | $398 | $261 | $110 |
| Liabilities | – | – | – | – |
| Payables | $69 | $33 | $17 | $12 |
| Short-Term Debt | $21 | $2 | $1 | $1 |
| Tax Payable | $49 | $12 | $7 | $0 |
| Deferred Revenue | $11 | $11 | $5 | $6 |
| Other Curr. Liab. | $181 | $101 | $56 | $19 |
| Total Curr. Liab. | $331 | $157 | $86 | $38 |
| LT Debt | $560 | $16 | $10 | $2 |
| Deferred Rev, NC | $3 | $12 | $23 | $23 |
| Deferred Tax Liab, NC | $9 | $4 | $5 | $0 |
| Other NC Liab. | $45 | $60 | $55 | $43 |
| Total NC Liab. | $617 | $92 | $93 | $68 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $11 | $8 | $7 | $3 |
| Total Liabilities | $948 | $249 | $175 | $106 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $597 | $446 | $371 | $171 |
| Retained Earnings | -$213 | -$264 | -$273 | -$173 |
| AOCI | $184 | -$34 | -$18 | $5 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $568 | $149 | $80 | $2 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,516 | $398 | $255 | $110 |
| Net Debt | -$129 | -$106 | -$106 | -$19 |